VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Lian Lian, Xiang-Li Li, Meng-Dan Xu, Xian-Min Li, Meng-Yao Wu, Yan Zhang, Min Tao, Wei Li, Xiao-Ming Shen, Chong Zhou, Min Jiang

ABSTRACT

BACKGROUND: VEGF/VEGFR2 pathway is the central therapeutic target in anti-angiogenic treatment in multiple cancers. However, little work has been carried out concerning the pro-malignancy functions of VEGFR2 that are independent of its pro-angiogenesis effects in gastric cancer. Here, we demonstrated that VEGFR2 up-regulation in gastric cancer tissues was a prognostic marker for poor disease-free survival and overall survival of gastric cancer patients. METHODS: Immunohistochemistry was used to detect VEGFR2 and VTN expressions in specimens. Kaplan-Meier curves were constructed for survival analysis. Stably knockdown cell lines and overexpression cell lines were constructed by small interfering RNA and plasmids transfection. Real-time PCR and Western blot were used to confirm the expressions of target genes at both RNA and protein levels. Cell proliferation was measured by using Cell Counting Kit-8 and xenograft models. Microarray and bioinformatic analysis were also performed to identify the relationship between Vitronectin (VTN) and VEGFR2. RESULTS: When overexpressed in gastric cancer cells, VEGFR2 increased cellular proliferation and invasion in vitro and tumor formation in xenograft models. By using integrating microarray and bioinformatic analysis, we identifiedVTN as a downstream of VEGFR2 pathway. In gain- and loss-of function analysis in gastric cancer cells, VTN was further verified in consistent with VEGFR2 in expression levels and in regulating cell growth and motility in vitro and in vivo. Moreover, in gastric cancer samples, VTN was as also revealed as a poor prognostic factor. CONCLUSIONS: Our present findings defined a novel activity for VEGFR2 in promoting tumorogenicity, motility and indicating a poor survival in gastric cancer beyond its known pro-angiogenic effects. IMPLICATIONS: Our present findings defined a novel activity for VEGFR2 in promoting tumorogenicity, motility and indicating a poor survival in gastric cancer beyond its known pro-angiogenic effects, which may provide a new and valuable target for design of therapies for intervention and a new cognitive perspective for the anti-angiogenesis therapies. More... »

PAGES

183

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-019-5322-0

DOI

http://dx.doi.org/10.1186/s12885-019-5322-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112462710

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30819137


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "First Affiliated Hospital of Soochow University", 
          "id": "https://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Oncology, Suzhou Xiangcheng People\u2019s Hospital, 215131, Suzhou, China", 
            "Department of Oncology, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lian", 
        "givenName": "Lian", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of General Surgery, Suzhou Xiangcheng People\u2019s Hospital, 215131, Suzhou, China", 
            "Comprehensive Cancer Center, Suzhou Xiangcheng People\u2019s Hospital, 215131, Suzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Xiang-Li", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Affiliated Hospital of Soochow University", 
          "id": "https://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Oncology, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xu", 
        "givenName": "Meng-Dan", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Oncology, Suzhou Xiangcheng People\u2019s Hospital, 215131, Suzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Xian-Min", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Affiliated Hospital of Soochow University", 
          "id": "https://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Oncology, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wu", 
        "givenName": "Meng-Yao", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Affiliated Hospital of Soochow University", 
          "id": "https://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Oncology, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Yan", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Affiliated Hospital of Soochow University", 
          "id": "https://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Oncology, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tao", 
        "givenName": "Min", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Affiliated Hospital of Soochow University", 
          "id": "https://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Oncology, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China", 
            "Comprehensive Cancer Center, Suzhou Xiangcheng People\u2019s Hospital, 215131, Suzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Wei", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Oncology, Suzhou Xiangcheng People\u2019s Hospital, 215131, Suzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shen", 
        "givenName": "Xiao-Ming", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Xuzhou Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.452207.6", 
          "name": [
            "Department of Radiation Oncology, Xuzhou Central Hospital, 221009, Xuzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "Chong", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Affiliated Hospital of Soochow University", 
          "id": "https://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Oncology, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jiang", 
        "givenName": "Min", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-13-1916", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001218731"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-13-1916", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001218731"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2014.257", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020969309", 
          "https://doi.org/10.1038/onc.2014.257"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13045-016-0340-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034701636", 
          "https://doi.org/10.1186/s13045-016-0340-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13045-016-0340-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034701636", 
          "https://doi.org/10.1186/s13045-016-0340-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/ol.2015.2958", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037248924"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/ol.2015.2958", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037248924"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.canlet.2016.01.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037437127"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/srep12120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039639010", 
          "https://doi.org/10.1038/srep12120"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm.2016.87", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043242363", 
          "https://doi.org/10.1038/nrm.2016.87"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbrc.2015.10.076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044220645"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.2910", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047358957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circresaha.107.155655", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049162746"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circresaha.107.155655", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049162746"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.55.9575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052929928"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4143/crt.2016.176", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072256121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074485303", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079237255", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.15252/emmm.201606840", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083735264"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-017-4189-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084025319", 
          "https://doi.org/10.1007/s10549-017-4189-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-017-4189-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084025319", 
          "https://doi.org/10.1007/s10549-017-4189-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7150/jca.17648", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084480904"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/bsr20170270", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085313362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0179202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085927781"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.canlet.2017.06.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090351344"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc.2017.51", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090661850", 
          "https://doi.org/10.1038/nrc.2017.51"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/13543784.2017.1361926", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090958512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-017-08796-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091313356", 
          "https://doi.org/10.1038/s41598-017-08796-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-017-08796-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091313356", 
          "https://doi.org/10.1038/s41598-017-08796-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2017.385", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092618351", 
          "https://doi.org/10.1038/bjc.2017.385"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: VEGF/VEGFR2 pathway is the central therapeutic target in anti-angiogenic treatment in multiple cancers. However, little work has been carried out concerning the pro-malignancy functions of VEGFR2 that are independent of its pro-angiogenesis effects in gastric cancer. Here, we demonstrated that VEGFR2 up-regulation in gastric cancer tissues was a prognostic marker for poor disease-free survival and overall survival of gastric cancer patients.\nMETHODS: Immunohistochemistry was used to detect VEGFR2 and VTN expressions in specimens. Kaplan-Meier curves were constructed for survival analysis. Stably knockdown cell lines and overexpression cell lines were constructed by small interfering RNA and plasmids transfection. Real-time PCR and Western blot were used to confirm the expressions of target genes at both RNA and protein levels. Cell proliferation was measured by using Cell Counting Kit-8 and xenograft models. Microarray and bioinformatic analysis were also performed to identify the relationship between Vitronectin (VTN) and VEGFR2.\nRESULTS: When overexpressed in gastric cancer cells, VEGFR2 increased cellular proliferation and invasion in vitro and tumor formation in xenograft models. By using integrating microarray and bioinformatic analysis, we identifiedVTN as a downstream of VEGFR2 pathway. In gain- and loss-of function analysis in gastric cancer cells, VTN was further verified in consistent with VEGFR2 in expression levels and in regulating cell growth and motility in vitro and in vivo. Moreover, in gastric cancer samples, VTN was as also revealed as a poor prognostic factor.\nCONCLUSIONS: Our present findings defined a novel activity for VEGFR2 in promoting tumorogenicity, motility and indicating a poor survival in gastric cancer beyond its known pro-angiogenic effects.\nIMPLICATIONS: Our present findings defined a novel activity for VEGFR2 in promoting tumorogenicity, motility and indicating a poor survival in gastric cancer beyond its known pro-angiogenic effects, which may provide a new and valuable target for design of therapies for intervention and a new cognitive perspective for the anti-angiogenesis therapies.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12885-019-5322-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7014378", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer", 
    "pagination": "183", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a5654bdfb26c9b95e225a45a2220b11f4f681f2986d9f5822a36dae1e2748f6c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30819137"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-019-5322-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112462710"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-019-5322-0", 
      "https://app.dimensions.ai/details/publication/pub.1112462710"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000356_0000000356/records_57865_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12885-019-5322-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5322-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5322-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5322-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5322-0'


 

This table displays all metadata directly associated to this object as RDF triples.

219 TRIPLES      21 PREDICATES      53 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-019-5322-0 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nc0595bf9d51a4efb8981eef51fe9f114
4 schema:citation sg:pub.10.1007/s10549-017-4189-5
5 sg:pub.10.1038/bjc.2017.385
6 sg:pub.10.1038/nrc.2017.51
7 sg:pub.10.1038/nrm.2016.87
8 sg:pub.10.1038/onc.2014.257
9 sg:pub.10.1038/s41598-017-08796-z
10 sg:pub.10.1038/srep12120
11 sg:pub.10.1186/s13045-016-0340-8
12 https://app.dimensions.ai/details/publication/pub.1074485303
13 https://app.dimensions.ai/details/publication/pub.1079237255
14 https://doi.org/10.1016/j.bbrc.2015.10.076
15 https://doi.org/10.1016/j.canlet.2016.01.010
16 https://doi.org/10.1016/j.canlet.2017.06.027
17 https://doi.org/10.1042/bsr20170270
18 https://doi.org/10.1080/13543784.2017.1361926
19 https://doi.org/10.1158/1078-0432.ccr-13-1916
20 https://doi.org/10.1161/circresaha.107.155655
21 https://doi.org/10.1200/jco.2014.55.9575
22 https://doi.org/10.1371/journal.pone.0179202
23 https://doi.org/10.15252/emmm.201606840
24 https://doi.org/10.18632/oncotarget.2910
25 https://doi.org/10.3892/ol.2015.2958
26 https://doi.org/10.4143/crt.2016.176
27 https://doi.org/10.7150/jca.17648
28 schema:datePublished 2019-12
29 schema:datePublishedReg 2019-12-01
30 schema:description BACKGROUND: VEGF/VEGFR2 pathway is the central therapeutic target in anti-angiogenic treatment in multiple cancers. However, little work has been carried out concerning the pro-malignancy functions of VEGFR2 that are independent of its pro-angiogenesis effects in gastric cancer. Here, we demonstrated that VEGFR2 up-regulation in gastric cancer tissues was a prognostic marker for poor disease-free survival and overall survival of gastric cancer patients. METHODS: Immunohistochemistry was used to detect VEGFR2 and VTN expressions in specimens. Kaplan-Meier curves were constructed for survival analysis. Stably knockdown cell lines and overexpression cell lines were constructed by small interfering RNA and plasmids transfection. Real-time PCR and Western blot were used to confirm the expressions of target genes at both RNA and protein levels. Cell proliferation was measured by using Cell Counting Kit-8 and xenograft models. Microarray and bioinformatic analysis were also performed to identify the relationship between Vitronectin (VTN) and VEGFR2. RESULTS: When overexpressed in gastric cancer cells, VEGFR2 increased cellular proliferation and invasion in vitro and tumor formation in xenograft models. By using integrating microarray and bioinformatic analysis, we identifiedVTN as a downstream of VEGFR2 pathway. In gain- and loss-of function analysis in gastric cancer cells, VTN was further verified in consistent with VEGFR2 in expression levels and in regulating cell growth and motility in vitro and in vivo. Moreover, in gastric cancer samples, VTN was as also revealed as a poor prognostic factor. CONCLUSIONS: Our present findings defined a novel activity for VEGFR2 in promoting tumorogenicity, motility and indicating a poor survival in gastric cancer beyond its known pro-angiogenic effects. IMPLICATIONS: Our present findings defined a novel activity for VEGFR2 in promoting tumorogenicity, motility and indicating a poor survival in gastric cancer beyond its known pro-angiogenic effects, which may provide a new and valuable target for design of therapies for intervention and a new cognitive perspective for the anti-angiogenesis therapies.
31 schema:genre research_article
32 schema:inLanguage en
33 schema:isAccessibleForFree true
34 schema:isPartOf N1ee79d7720d340768ffc7c34cadca77e
35 N3a1f03347a054b3aadf043127e59e8a4
36 sg:journal.1024632
37 schema:name VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer
38 schema:pagination 183
39 schema:productId N0790ff111f344aa88582d9596fa4de52
40 N739e323306e248f793a1f8ff0708344b
41 N81dfe25b9e614e498db5e6ca881106f1
42 Na9e73ac5436b45b4a5befd51fb7b73bd
43 Nb9e18e6a3b114696b454c7a152defa91
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112462710
45 https://doi.org/10.1186/s12885-019-5322-0
46 schema:sdDatePublished 2019-04-11T11:25
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher Nacbbdd8ecd6e4fd1a481b0839106ca19
49 schema:url https://link.springer.com/10.1186%2Fs12885-019-5322-0
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N0433cdef25da45f0acd719cfb503f95f schema:affiliation Ne9440f9a8270474b9f119ffbce877cb4
54 schema:familyName Li
55 schema:givenName Xian-Min
56 rdf:type schema:Person
57 N0790ff111f344aa88582d9596fa4de52 schema:name dimensions_id
58 schema:value pub.1112462710
59 rdf:type schema:PropertyValue
60 N086a6180df1242829af6ff8d73fd4029 rdf:first N3410e30ed9804c61b40f002224652a7b
61 rdf:rest N1be0c70d7e5148e29ae47265ff4e4ae2
62 N1be0c70d7e5148e29ae47265ff4e4ae2 rdf:first N3cf08d03c74a418a833e1261df0198d6
63 rdf:rest rdf:nil
64 N1cd2507fa3ba4be39eac75ed986679ad schema:affiliation N5e65fd1dfad8450f9b7b3e5d10f028cc
65 schema:familyName Li
66 schema:givenName Xiang-Li
67 rdf:type schema:Person
68 N1ee79d7720d340768ffc7c34cadca77e schema:issueNumber 1
69 rdf:type schema:PublicationIssue
70 N220bd9be867c4d05b4c6d5d47fd5e5cd rdf:first N407dac419a664f459e5fee9c949b0051
71 rdf:rest Nadbcfa123b1e447898020558bc27d41c
72 N2a5a12dece0c44859138de5b69422ee4 schema:affiliation Nc72f48952c5446dfa825cb930c4f277d
73 schema:familyName Shen
74 schema:givenName Xiao-Ming
75 rdf:type schema:Person
76 N2f3bc79392b94476b1fc1061299d5e6e schema:affiliation https://www.grid.ac/institutes/grid.429222.d
77 schema:familyName Wu
78 schema:givenName Meng-Yao
79 rdf:type schema:Person
80 N32411e64ca68414a82c76ecd9020ae63 rdf:first Nc8a2b933c3874f368503efeccbe50bb8
81 rdf:rest Nc8abab5611434b2c964ea96a8f278e50
82 N3410e30ed9804c61b40f002224652a7b schema:affiliation https://www.grid.ac/institutes/grid.452207.6
83 schema:familyName Zhou
84 schema:givenName Chong
85 rdf:type schema:Person
86 N3618055a8b8f4fda9b638401c7ae9fe0 schema:affiliation https://www.grid.ac/institutes/grid.429222.d
87 schema:familyName Zhang
88 schema:givenName Yan
89 rdf:type schema:Person
90 N3a1f03347a054b3aadf043127e59e8a4 schema:volumeNumber 19
91 rdf:type schema:PublicationVolume
92 N3cf08d03c74a418a833e1261df0198d6 schema:affiliation https://www.grid.ac/institutes/grid.429222.d
93 schema:familyName Jiang
94 schema:givenName Min
95 rdf:type schema:Person
96 N407dac419a664f459e5fee9c949b0051 schema:affiliation https://www.grid.ac/institutes/grid.429222.d
97 schema:familyName Li
98 schema:givenName Wei
99 rdf:type schema:Person
100 N5e65fd1dfad8450f9b7b3e5d10f028cc schema:name Comprehensive Cancer Center, Suzhou Xiangcheng People’s Hospital, 215131, Suzhou, China
101 Department of General Surgery, Suzhou Xiangcheng People’s Hospital, 215131, Suzhou, China
102 rdf:type schema:Organization
103 N6c98cbb21b514ee594f8aeab2b905974 rdf:first Na3086b5306624680834a7a74adb14c3f
104 rdf:rest N220bd9be867c4d05b4c6d5d47fd5e5cd
105 N739e323306e248f793a1f8ff0708344b schema:name pubmed_id
106 schema:value 30819137
107 rdf:type schema:PropertyValue
108 N81dfe25b9e614e498db5e6ca881106f1 schema:name readcube_id
109 schema:value a5654bdfb26c9b95e225a45a2220b11f4f681f2986d9f5822a36dae1e2748f6c
110 rdf:type schema:PropertyValue
111 Na3086b5306624680834a7a74adb14c3f schema:affiliation https://www.grid.ac/institutes/grid.429222.d
112 schema:familyName Tao
113 schema:givenName Min
114 rdf:type schema:Person
115 Na9e73ac5436b45b4a5befd51fb7b73bd schema:name nlm_unique_id
116 schema:value 100967800
117 rdf:type schema:PropertyValue
118 Nacbbdd8ecd6e4fd1a481b0839106ca19 schema:name Springer Nature - SN SciGraph project
119 rdf:type schema:Organization
120 Nadbcfa123b1e447898020558bc27d41c rdf:first N2a5a12dece0c44859138de5b69422ee4
121 rdf:rest N086a6180df1242829af6ff8d73fd4029
122 Nb24ef412e88d484994ad396f3a1c7bdf rdf:first N3618055a8b8f4fda9b638401c7ae9fe0
123 rdf:rest N6c98cbb21b514ee594f8aeab2b905974
124 Nb9e18e6a3b114696b454c7a152defa91 schema:name doi
125 schema:value 10.1186/s12885-019-5322-0
126 rdf:type schema:PropertyValue
127 Nc0595bf9d51a4efb8981eef51fe9f114 rdf:first Nd3937c1c9aba4d9a87068c4ccaa9f14d
128 rdf:rest Nc76725d2236040c088edf09a9897de2b
129 Nc72f48952c5446dfa825cb930c4f277d schema:name Department of Oncology, Suzhou Xiangcheng People’s Hospital, 215131, Suzhou, China
130 rdf:type schema:Organization
131 Nc76725d2236040c088edf09a9897de2b rdf:first N1cd2507fa3ba4be39eac75ed986679ad
132 rdf:rest N32411e64ca68414a82c76ecd9020ae63
133 Nc8a2b933c3874f368503efeccbe50bb8 schema:affiliation https://www.grid.ac/institutes/grid.429222.d
134 schema:familyName Xu
135 schema:givenName Meng-Dan
136 rdf:type schema:Person
137 Nc8abab5611434b2c964ea96a8f278e50 rdf:first N0433cdef25da45f0acd719cfb503f95f
138 rdf:rest Nccd71a9c4f8f4a798f91a48e25072c56
139 Nccd71a9c4f8f4a798f91a48e25072c56 rdf:first N2f3bc79392b94476b1fc1061299d5e6e
140 rdf:rest Nb24ef412e88d484994ad396f3a1c7bdf
141 Nd3937c1c9aba4d9a87068c4ccaa9f14d schema:affiliation https://www.grid.ac/institutes/grid.429222.d
142 schema:familyName Lian
143 schema:givenName Lian
144 rdf:type schema:Person
145 Ne9440f9a8270474b9f119ffbce877cb4 schema:name Department of Oncology, Suzhou Xiangcheng People’s Hospital, 215131, Suzhou, China
146 rdf:type schema:Organization
147 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
148 schema:name Medical and Health Sciences
149 rdf:type schema:DefinedTerm
150 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
151 schema:name Oncology and Carcinogenesis
152 rdf:type schema:DefinedTerm
153 sg:grant.7014378 http://pending.schema.org/fundedItem sg:pub.10.1186/s12885-019-5322-0
154 rdf:type schema:MonetaryGrant
155 sg:journal.1024632 schema:issn 1471-2407
156 schema:name BMC Cancer
157 rdf:type schema:Periodical
158 sg:pub.10.1007/s10549-017-4189-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084025319
159 https://doi.org/10.1007/s10549-017-4189-5
160 rdf:type schema:CreativeWork
161 sg:pub.10.1038/bjc.2017.385 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092618351
162 https://doi.org/10.1038/bjc.2017.385
163 rdf:type schema:CreativeWork
164 sg:pub.10.1038/nrc.2017.51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090661850
165 https://doi.org/10.1038/nrc.2017.51
166 rdf:type schema:CreativeWork
167 sg:pub.10.1038/nrm.2016.87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043242363
168 https://doi.org/10.1038/nrm.2016.87
169 rdf:type schema:CreativeWork
170 sg:pub.10.1038/onc.2014.257 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020969309
171 https://doi.org/10.1038/onc.2014.257
172 rdf:type schema:CreativeWork
173 sg:pub.10.1038/s41598-017-08796-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1091313356
174 https://doi.org/10.1038/s41598-017-08796-z
175 rdf:type schema:CreativeWork
176 sg:pub.10.1038/srep12120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039639010
177 https://doi.org/10.1038/srep12120
178 rdf:type schema:CreativeWork
179 sg:pub.10.1186/s13045-016-0340-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034701636
180 https://doi.org/10.1186/s13045-016-0340-8
181 rdf:type schema:CreativeWork
182 https://app.dimensions.ai/details/publication/pub.1074485303 schema:CreativeWork
183 https://app.dimensions.ai/details/publication/pub.1079237255 schema:CreativeWork
184 https://doi.org/10.1016/j.bbrc.2015.10.076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044220645
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/j.canlet.2016.01.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037437127
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/j.canlet.2017.06.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090351344
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1042/bsr20170270 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085313362
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1080/13543784.2017.1361926 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090958512
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1158/1078-0432.ccr-13-1916 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001218731
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1161/circresaha.107.155655 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049162746
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1200/jco.2014.55.9575 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052929928
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1371/journal.pone.0179202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085927781
201 rdf:type schema:CreativeWork
202 https://doi.org/10.15252/emmm.201606840 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083735264
203 rdf:type schema:CreativeWork
204 https://doi.org/10.18632/oncotarget.2910 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047358957
205 rdf:type schema:CreativeWork
206 https://doi.org/10.3892/ol.2015.2958 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037248924
207 rdf:type schema:CreativeWork
208 https://doi.org/10.4143/crt.2016.176 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072256121
209 rdf:type schema:CreativeWork
210 https://doi.org/10.7150/jca.17648 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084480904
211 rdf:type schema:CreativeWork
212 https://www.grid.ac/institutes/grid.429222.d schema:alternateName First Affiliated Hospital of Soochow University
213 schema:name Comprehensive Cancer Center, Suzhou Xiangcheng People’s Hospital, 215131, Suzhou, China
214 Department of Oncology, Suzhou Xiangcheng People’s Hospital, 215131, Suzhou, China
215 Department of Oncology, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China
216 rdf:type schema:Organization
217 https://www.grid.ac/institutes/grid.452207.6 schema:alternateName Xuzhou Central Hospital
218 schema:name Department of Radiation Oncology, Xuzhou Central Hospital, 221009, Xuzhou, China
219 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...